Acrivon Therapeutics, Inc. (ACRV) — Capital Expenditures
| Fiscal Year | Capital Expenditures | Change YoY |
|---|---|---|
| 2025 | $1.67M | -39.7% |
| 2024 | $2.77M | +114.9% |
| 2023 | $1.29M | -40.5% |
| 2022 | $2.17M | +810.1% |
| 2021 | $238.0K | — |
| Fiscal Year | Capital Expenditures | Change YoY |
|---|---|---|
| 2025 | $1.67M | -39.7% |
| 2024 | $2.77M | +114.9% |
| 2023 | $1.29M | -40.5% |
| 2022 | $2.17M | +810.1% |
| 2021 | $238.0K | — |